Format

Send to

Choose Destination
See comment in PubMed Commons below
Magy Onkol. 2012 Dec;56(4):247-57. doi: MagyOnkol.2012.56.4.247. Epub 2012 Sep 20.

[Complex psycho-social intervention program complementing conventional antitumor therapy -- promising results].

[Article in Hungarian]

Author information

1
Alkalmazott Pszichológia Tanszék, Semmelweis Egyetem ETK, Budapest, Hungary. kovacszs@se-etk.hu

Abstract

The aim of the research was to assess the effectiveness of a comprehensive, complex psycho-social intervention program, operating on different levels of spiritual plane, life management and behavioural health, among women with breast cancer. The general objective of the study was to help in coping, promote cognitive and emotional processing, encourage psychological and spiritual growth, improve the quality of life, and reduce the chances of remission. The research has been carried out in Budapest at the Radiology Diagnostic Department of the National Oncology Institute, involving 173 women treated for malignant breast tumour (C50) (experimental group: n=86, control group: n=87). Thirty-four women from the experimental group participated in the complex intervention program. We carried out two tests: one before the start and one after the end of the program. Research tools: Shortened Beck Depression Inventory, Quality of Life Questionnaire (EORTC QLQ-C30, QLQ-BR23), Spielberger's State-Trait Anxiety Inventory (STAI-T), the Revised Illness Perception Questionnaire (IPQ-R), the Posttraumatic Growth Inventory, and the Benefit Finding Questionnaire. The women participating the experimental program showed a significant positive change in comparison to the control group: in anxiety F (1, 65)=6.021, p=0.017; in depression: F(1, 72)=4.347, p=0.041; in experience of personal control: F(1, 69)=7.346, p=0.008; in EORTC General Health/Quality of Life Subscale F(1, 78)=7.531, p=0.008; in EORTC physical functioning F(1, 78)=4.874, p=0.014; in EORTC fatigue F(1, 78)=15.060, p=0.000; in BR23 body-image F(1, 79)=8.828, p=0.004; in BR23 arm symptoms F(1, 78)=7.229, p=0.009; in benefit finding F(1, 80)=21.171, p=0.000, and in posttraumatic growth F(1, 31)=24.186, p=0.000). The program has proven effective, its widespread use in practice is recommended.

PMID:
23236595
DOI:
MagyOnkol.2012.56.4.247
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hungarian Oncological Association
    Loading ...
    Support Center